GB1337921A - Aminopropanol derivative - Google Patents

Aminopropanol derivative

Info

Publication number
GB1337921A
GB1337921A GB1233472A GB1233472A GB1337921A GB 1337921 A GB1337921 A GB 1337921A GB 1233472 A GB1233472 A GB 1233472A GB 1233472 A GB1233472 A GB 1233472A GB 1337921 A GB1337921 A GB 1337921A
Authority
GB
United Kingdom
Prior art keywords
march
aminopropanol derivative
racemio
propanolamines
comptroller
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1233472A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of GB1337921A publication Critical patent/GB1337921A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms

Abstract

1337921 Propanolamines RICHTER GEDEON VEGYESZETI GYAR RT 16 March 1972 [17 March 1971] 12334/72 Heading C2C Racemic and optically active 1-(2,5-dichlorophenoxy) - 3 - tert. - butylamino - 2 - propanol and its salts are prepared by standard methods. The racemio and l-forms are #-adrenergic blocking agents and the d-form is an antiarrhythmic agent; they may be administered in the form of pharmaceutical preparations containing them in association with a carrier. Reference has been directed by the Comptroller to Specifications 1,069,341 and 1,069,345.
GB1233472A 1971-03-17 1972-03-16 Aminopropanol derivative Expired GB1337921A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUGO001156 1971-03-17

Publications (1)

Publication Number Publication Date
GB1337921A true GB1337921A (en) 1973-11-21

Family

ID=10996691

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1233472A Expired GB1337921A (en) 1971-03-17 1972-03-16 Aminopropanol derivative

Country Status (19)

Country Link
JP (1) JPS5310581B1 (en)
AT (1) AT316515B (en)
AU (1) AU461159B2 (en)
BE (1) BE780719A (en)
CA (1) CA1002537A (en)
CH (1) CH569692A5 (en)
CS (1) CS163270B2 (en)
DK (1) DK133872B (en)
ES (1) ES401235A1 (en)
FI (1) FI55025C (en)
FR (1) FR2130284B1 (en)
GB (1) GB1337921A (en)
IL (1) IL38870A (en)
NL (1) NL170626C (en)
NO (1) NO134836C (en)
PL (1) PL88985B1 (en)
SE (1) SE384021B (en)
SU (1) SU496721A3 (en)
YU (1) YU35435B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310549A (en) 1976-03-02 1982-01-12 Andor Hajos Treatment of hypertension with 1-tert.-butylamino-3-(2,5-dichlorophenoxy)-2-propanol

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1236523C2 (en) * 1962-02-15 1975-06-12 Sanol-Arzneimittel Dr. Schwarz Gmbh, 4019 Monheim PROCESS FOR THE PRODUCTION OF BASIC PHENYLAETHERS AND THEIR SALTS

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310549A (en) 1976-03-02 1982-01-12 Andor Hajos Treatment of hypertension with 1-tert.-butylamino-3-(2,5-dichlorophenoxy)-2-propanol

Also Published As

Publication number Publication date
NL170626B (en) 1982-07-01
PL88985B1 (en) 1976-10-30
DK133872C (en) 1976-12-27
IL38870A0 (en) 1972-05-30
AU461159B2 (en) 1975-04-29
YU63972A (en) 1980-06-30
ES401235A1 (en) 1975-02-16
NL170626C (en) 1982-12-01
YU35435B (en) 1981-02-28
FI55025B (en) 1979-01-31
FR2130284A1 (en) 1972-11-03
AT316515B (en) 1974-07-10
SU496721A3 (en) 1975-12-25
CA1002537A (en) 1976-12-28
DE2213044B2 (en) 1977-05-26
FI55025C (en) 1979-05-10
NO134836C (en) 1976-12-21
BE780719A (en) 1972-07-03
NO134836B (en) 1976-09-13
SE384021B (en) 1976-04-12
DE2213044A1 (en) 1972-09-28
CH569692A5 (en) 1975-11-28
AU3965972A (en) 1973-09-13
JPS5310581B1 (en) 1978-04-14
CS163270B2 (en) 1975-08-29
NL7203323A (en) 1972-09-19
DK133872B (en) 1976-08-02
FR2130284B1 (en) 1975-10-10
IL38870A (en) 1975-08-31

Similar Documents

Publication Publication Date Title
GB1330878A (en) Ketamine resolution
GB1147379A (en) 4-alkyl-dialkoxy-ª‡-methylphenethylamines and pharmacologically acceptable salts
GB1188846A (en) Thiazole Derivatives
GB1337921A (en) Aminopropanol derivative
GB1178721A (en) Improvements in and relating to Novel Phenoxypropylamines
GB1475314A (en) Phenyl-propylamine derivatives
GB1296414A (en)
GB1216295A (en) New enzyme inhibitors and their preparation
GB1373271A (en) Indoles
GB1418288A (en) Anti-hypertensive compositions
GB1387803A (en) Watersoluble salts of polyhydroxyphenylchromanones
GB1327930A (en) 1,4-benzodiazepine derivatives
GB1391081A (en) Optically active benzodiazepines
GB1229265A (en)
GB1222294A (en) Oxazinobenzodiazepine derivatives
GB1217138A (en) Pharmaceutical compositions based on derivatives of benzimidazole
GB1183847A (en) Diphenyl Derivatives
GB1377787A (en) Aminopropanol derivatives
GB1256735A (en)
ES385521A1 (en) Azamorphinan compounds
GB1378296A (en) Pharmaceutical composition
GB1329130A (en) Isoindolo 1,2-b benzothiazol-11 -4bh- one 5-oxides
GB1380754A (en) Pharmaceutical compositions comprising semi-esters of dicarboxylic acids
ES370500A1 (en) Procedure for the preparation of the hydracide. (Machine-translation by Google Translate, not legally binding)
GB1135584A (en) Anorexigenic compositions comprising -ß-phenylethylamine derivatives

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years